ITMAXICO Labs
In development

Verdikt

Works or worthless: an evidence verdict on any supplement

A living systematic review. The engine collects world research on drugs, supplements and peptides and rates each one: works, disputed or worthless.

WorksDisputedWorthless
Semax
323 publications · 2 RCTs
323publications analysed for Semax alone
2RCTs found among them
6stages in the evidence pipeline
The idea

The supplement market runs on advertising. We sell nothing, only evidence. A verdict that recalculates with every new study never goes stale.

The problem

In a market worth tens of billions, people choose by advertising, not data. Articles and books go stale the day they are printed.

What it does

A six-stage pipeline scores each compound against a specific health goal and recalculates with every new study. Example: Semax is rated “disputed” on 323 publications and 2 RCTs.

Who it is for

People

Check a supplement before paying for it.

Doctors and clinics

Evidence at hand during an appointment.

Marketplaces and makers

License verdicts and market analytics.

Where it is now

Global longevity and supplements

Idea
Prototype
Pilot
Live
US launch

Business model

Subscription

For individuals and doctors.

API and license

For clinics, marketplaces and manufacturers.

B2B analytics

Supplement market intelligence. We sell evidence, never products.

The team

MM

Maxim Marchenko

Founder · product and strategy

18 years in IT. Founder of MAXICO, an Astana Hub resident, and of ITMAXICO LLC in Wyoming.

Mt

MAXICO team

Design · engineering · AI

The studio team behind every product in the portfolio: web and mobile, AI agents, data pipelines and integrations.

Want a demo, a pilot or a seat in the round?

Write a few lines about your company. You get an answer within one business day.